Patents by Inventor Matt McCarty

Matt McCarty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11991418
    Abstract: Methods and apparatus for implementing a playback system capable of operating as a virtual or augmented reality device are described. In various embodiment one or more environmental triggers are detected and an action is taken based on the detected trigger, user input and/or other environmental conditions. The methods allow a user who is subject to an immersive experience to smoothly transition in/or out of the virtual environment and respond to environmental triggers which may require a user to take an action.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: May 21, 2024
    Assignee: Nevermind Capital LLC
    Inventors: Matt McCarty, Hector Medina, David Cole, Alan Moss
  • Publication number: 20240027334
    Abstract: Provided herein are methods for determining if a urine sample comprises synthetic urine, methods for matching a urine sample to a subject, and methods for amplifying DNA. Also provided are kits that include a set of at least 3 pairs of a pre-amplification forward and reverse primer, where each pair of pre-amplification forward and reverse primers is designed to amplify 250 to 300 nucleotides of genomic DNA that contains one of at least 3 SNPs, where the pre-amplification forward and reverse primers in each of the three or more pairs of pre-amplification primers contains (i) a sequence of about 17 to about 25 contiguous nucleotides that is complementary to a sequence in the genomic DNA and (i) a tag sequence of about 17 to about 25 contiguous nucleotides that is not complementary to a sequence in the genomic DNA.
    Type: Application
    Filed: September 28, 2022
    Publication date: January 25, 2024
    Inventors: Matt McCarty, Keqin Gregg
  • Publication number: 20180328912
    Abstract: Provided herein are methods of matching a urine sample to a subject that include enriching a urine sample for mammalian cells, isolating any genomic DNA from the enriched sample to form an isolated genomic DNA sample, contacting a set of two or more oligonucleotide probes to the genomic DNA in the isolated genomic DNA test sample, where each of the two or more oligonucleotide probes hybridizes to a sequence of genomic DNA that is one nucleotide upstream of a different target single nucleotide polymorphism (SNP), elongating the two or more oligonucleotide probes to generate a set of two or more SNP amplification products; determining the mass distribution of the set of two or more SNP amplification products; and comparing the determined mass distribution of the set of SNP products to a control mass distribution.
    Type: Application
    Filed: January 19, 2018
    Publication date: November 15, 2018
    Applicant: Genotox ID LLC
    Inventor: Matt McCarty
  • Publication number: 20160145684
    Abstract: Provided herein are methods for determining if a urine sample comprises synthetic urine, methods for matching a urine sample to a subject, and methods for amplifying DNA. Also provided are kits that include a set of at least 3 pairs of a pre-amplification forward and reverse primer, where each pair of pre-amplification forward and reverse primers is designed to amplify 250 to 300 nucleotides of genomic DNA that contains one of at least 3 SNPs, where the pre-amplification forward and reverse primers in each of the three or more pairs of pre-amplification primers contains (i) a sequence of about 17 to about 25 contiguous nucleotides that is complementary to a sequence in the genomic DNA and (i) a tag sequence of about 17 to about 25 contiguous nucleotides that is not complementary to a sequence in the genomic DNA.
    Type: Application
    Filed: June 26, 2015
    Publication date: May 26, 2016
    Inventors: Matt McCarty, Keqin Gregg